Concepedia

S. H. KRAWCZYK

SH

Statistics

Publications

7

Citations

438

H-Index

7

Active since

1987

Affiliations

Gilead Sciences (United States)(Current)

University of Michigan

S. H. KRAWCZYK is an author at Gilead Sciences (United States) specializing in medicine, pharmacology, and antiviral pharmacology.

Publications per year

1987–2013

7

Publications

7

Triple helix formation inhibits transcription elongation in vitro.

Stuart Young, S. H. KRAWCZYK, Mark D. Matteucci et al. · Proceedings of the National Academy of Sciences · 1991 · 171 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Pyrrolo[2,3-d]pyrimidine nucleosides as inhibitors of human cytomegalovirus

Steven R. Turk, C. Shipman, Reza Nassiri et al. · Antimicrobial Agents and Chemotherapy · 1987 · 90 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Oligonucleotide-mediated triple helix formation using an N3-protonated deoxycytidine analog exhibiting pH-independent binding within the physiological range.

S. H. KRAWCZYK, John F. Milligan, Shalini Wadwani et al. · Proceedings of the National Academy of Sciences · 1992 · 84 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Synthesis and Antiproliferative and Antiviral Activity of 2'-Deoxy-2'-fluoroarabinofuranosyl Analogs of the Nucleoside Antibiotics Toyocamycin and Sangivamycin

S. H. KRAWCZYK, Mahmoud Nassiri, Louis S. Kucera et al. · Journal of Medicinal Chemistry · 1995 · 40 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +11

The Predominant Protective Effect of Tianeptine Over Other Antidepressants in Models of Neuronal Apoptosis: The Effect Blocked by Inhibitors of MAPK/ERK1/2 and PI3-K/Akt Pathways

Danuta Jantas, S. H. KRAWCZYK, Władysław Lasoń · Neurotoxicity Research · 2013 · 29 citations · Full text

Medicine, Neuroscience, Pharmacology +17

1–5 of 7